Accession Number: | 0001104659-20-003100 |
Date: | 2020-01-08 |
Issuer: | MARINUS PHARMACEUTICALS INC (MRNS) |
Original Submission Date: |
SMITH EDWARD F
C/O MARINUS PHARMA, 5 RADNOR CORP CENT,
SUITE 500 100 MATSONFORD RD
RADNOR, PA 19087
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.07 | 2020-01-08 | deemed execution date | A | 765,000 (a) | 2030-01-08 | common stock 765,000 | $2.07 | 765,000 | direct |
ID | footnote |
---|---|
f1 | options to purchase shares of common stock vest in 36 equal monthly installments, commencing on 1/31/20. |